Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+16.0%
5Y CAGR+11.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+16.0%/yr
vs +36.0%/yr prior
5Y CAGR
+11.9%/yr
Recent acceleration
Acceleration
-20.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $142.04M | +14.6% |
| 2025 | $123.94M | +28.0% |
| 2024 | $96.82M | +6.5% |
| 2023 | $90.93M | -26.9% |
| 2022 | $124.43M | +53.7% |
| 2021 | $80.98M | +54.9% |
| 2020 | $52.28M | +96.9% |
| 2019 | $26.56M | +39.0% |
| 2018 | $19.11M | +9.2% |
| 2017 | $17.50M | - |